{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:30:31Z","timestamp":1790832631504,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.waojou.2024.100893","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:45:10Z","timestamp":1712450710000},"page":"100893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the frequency and characteristics of drug hypersensitivity reactions in hospitalized children: Real life-cohort study"],"prefix":"10.1016","volume":"17","author":[{"given":"\u015eule","family":"B\u00fcy\u00fck Yaytokgil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Selmanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilknur","family":"Kulhas Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"\u015eeng\u00fcl Emeksiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfur","family":"Ginis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"Karaatmaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Toyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersoy","family":"Civelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Dibek Misirlio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2024.100893_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100893_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8010-9","article-title":"A\u00a0complex interactiob between drug allergy and viral infection","volume":"33","author":"Shiohara","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.waojou.2024.100893_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1081-1206(10)61804-2","article-title":"Drug allergy in a general hospital results of a novel prospective inpatient reporting system","volume":"90","author":"Thong","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2024.100893_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.23822\/EurAnnACI.1764-1489.18","article-title":"Pattern of inpatient referrals to a drug allergy unit in Kuwait","volume":"49","author":"Al-ahmad","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.100893_bib5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1034\/j.1398-9995.1999.00247.x","article-title":"Drug hypersensitivity: questionnaire: EAACI interest group on drug hypersensitivity","volume":"54","author":"Demoly","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.100893_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.waojou.2024.100893_bib7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2024.100893_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/idoj.idoj_196_21","article-title":"RegiSCAR DRESS (drug reaction with eosinophilia and systemic symptoms) validation scoring system and Japanese consensus group criteria for atypical drug-induced hypersensitivity syndrome (DiHS): a comparative analysis","volume":"13","author":"Sasidharanpillai","year":"2022","journal-title":"Indian Dermatol Online J."},{"issue":"8","key":"10.1016\/j.waojou.2024.100893_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1398-9995.2007.01421.x","article-title":"EAACI Task Force on Anaphylaxis in Children. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology","volume":"62","author":"Muraro","year":"2007","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.waojou.2024.100893_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.waojou.2024.100893_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.13562","article-title":"EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity","volume":"74","author":"Brockow","year":"2019","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2024.100893_bib12","first-page":"205","article-title":"Adverse drug reactions and causality: the Turkish version of Naranjo adverse drug reactions probability scale","volume":"27","author":"Kose","year":"2017","journal-title":"Psych Clin Psychopharmacol"},{"key":"10.1016\/j.waojou.2024.100893_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1399-3038.2010.01115.x","article-title":"Classification of anaphylais and utility of the EAACI Taskforce position paper an anaphylaxis in children","volume":"22","author":"Vetander","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.waojou.2024.100893_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.100893_bib15","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity reactions: general consideration","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.100893_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity- a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.100893_bib17","first-page":"293","article-title":"National guideline update on approach to drug hypersensitivity reactions 2019","volume":"2019","author":"\u00c7elik","year":"2019","journal-title":"Asthma Allergy Immunology"},{"issue":"3","key":"10.1016\/j.waojou.2024.100893_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2016.09.041","article-title":"Identifying allergic drug reactions through placebo-controlled graded challenges","volume":"5","author":"Iammatteo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Practice"},{"issue":"8","key":"10.1016\/j.waojou.2024.100893_bib19","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.jaip.2021.04.008","article-title":"Treating through of drug \u2013 associates exanthem in drug allergy management: current evidence and clinical aspect","volume":"9","author":"Trubiano","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Practice"},{"issue":"6","key":"10.1016\/j.waojou.2024.100893_bib20","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jaip.2017.03.032","article-title":"\u201cTreating through\u201d decision and follow-up in antibiotic therapy-associated exanthemas","volume":"5","author":"Trautmann","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.waojou.2024.100893_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2013an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.100893_bib22","first-page":"1","article-title":"Drug induced hypersensitivity: a 5 year retrospective study in a hospital electronic health records database","author":"Mendes","year":"2018","journal-title":"J\u00a0Clin Pharm Therapeut"},{"issue":"20","key":"10.1016\/j.waojou.2024.100893_bib23","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1001\/jama.1991.03470200059035","article-title":"Computerized surveillance of adverse drug events in hospital patients","volume":"266","author":"Classen","year":"1991","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.waojou.2024.100893_bib24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/pds.1612","article-title":"The use of an electronic medical record system for mandatory reporting of drug hypersensitivity reactions has been shown to improve the management of patients in the university hospital in Korea","volume":"17","author":"Park","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.waojou.2024.100893_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.arcmed.2006.03.010","article-title":"Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients","volume":"37","author":"Hern\u00e1ndez-Salazar","year":"2006","journal-title":"Arch Med Res"},{"issue":"9","key":"10.1016\/j.waojou.2024.100893_bib26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00403-015-1589-4","article-title":"Incidence of adverse cutaneous drug reactions in 22 866 Chinese inpatients: a prospective study","volume":"307","author":"Tian","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.waojou.2024.100893_bib27","first-page":"1","article-title":"Skin eruptions in children: drug hypersensitivity vs viral exanthema","volume":"00","author":"Tsabouri","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2024.100893_bib28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3109\/10428194.2011.635864","article-title":"High incidence of skin rash in patients with hairy cell leukemia treated with cladribine","volume":"53","author":"Ganzel","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.waojou.2024.100893_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/pai.12020","article-title":"Diagnosing multiple drug hypersensitivity in children","volume":"23","author":"Atanascovic-Marcovic","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2024.100893_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anai.2018.09.447","article-title":"Proven immunologically mediated drug hypersensitivity in children with a history of multiple drug intolerances","volume":"122","author":"Guvenir","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2024.100893_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2500\/aap.2021.42.200128","article-title":"Safety and efficacy of direct two step penicillin challenges with an inpatient pharmacist-driven allergy evaluation","volume":"42","author":"Ham","year":"2021","journal-title":"Allergy Asthma Proceeding"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T08:26:54Z","timestamp":1713428814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455124000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1939455124000243"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100893","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the frequency and characteristics of drug hypersensitivity reactions in hospitalized children: Real life-cohort study","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2024.100893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100893"}}